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Microglia– brain macrophages are immune-competent cells of the CNS and respond to pathologic events. Using bacterial lipopolysac-
charide (LPS) as a tool to activate cultured mouse microglia, we studied alterations in the intracellular calcium concentration ([Ca 2]i )
and in the receptor-evoked generation of transient calcium signals. LPS treatment led to a chronic elevation of basal [Ca 2]i along with
a suppression of evoked calcium signaling, as indicated by reduced [Ca 2]i transients during stimulation with UTP and complement
factor 5a. Presence of the calcium chelator BAPTA prevented the activation-associated changes in [Ca 2]i and restored much of the
signaling efficacy. We also evaluated downstream consequences of a basal [Ca 2]i lifting during microglial activation and found BAPTA
to strongly attenuate the LPS-induced release of nitric oxide (NO) and certain cytokines and chemokines. Furthermore, microglial
treatment with ionomycin, an ionophore elevating basal [Ca 2]i , mimicked the activation-induced calcium signal suppression but failed
to induce release activity on its own. Our findings suggest that chronic elevation of basal [Ca 2]i attenuates receptor-triggered calcium
signaling. Moreover, increased [Ca 2]i is required, but by itself is not sufficient, for release of NO and certain cytokines and chemokines.
Elevation of basal [Ca 2]i could thus prove a central element in the regulation of executive functions in activated microglia.
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Introduction
Microglia constitutes the macrophage equivalent of the CNS. In
response to pathological events, the normally “resting” microglia
gradually transform into motile, secretory active and potentially
cytotoxic phagocytes (Kreutzberg, 1996; Schwaiger et al., 1998;
Raivich et al., 1999a; Streit et al., 2000; Hanisch, 2001). Activated
microglial cells then participate in mechanisms of innate and
immune defense, tissue repair, and neuroprotection. However,
experimental and clinical evidence also supports the notion that
excessive microglial activation exacerbates destructive cascades.
Microglia express a variety of receptors that allow for a mon-
itoring of the surrounding tissue (No¨renberg et al., 1994;
Kreutzberg, 1996; Streit et al., 2000). Receptors for neurotrans-
mitters and cotransmitters could be important for sensing neu-
ronal activity, and microglia express functional glutamatergic,
adrenergic, and purinoreceptors (Noda et al., 2000; Prinz et al.,
2001). Abnormal receptor signaling (excessive intensities or dis-
ruption) could indicate homeostatic disturbance and trigger mi-
croglial responses. Microglia also express receptors for immune
system mediators, namely for cytokines, chemokines, and com-
plement (Mo¨ller et al., 1997; Harrison et al., 1998; Raivich et al.,
1999b; Hanisch, 2001). Some of these factors may play physio-
logical roles in the developing and healthy adult CNS. Others
appear only under pathological conditions (Hopkins and Roth-
well, 1995; Merrill and Benveniste, 1996; Hanisch, 2002; Ha¨usler
et al., 2002). Some receptors are upregulated during activation
(Raivich et al., 1998). In contrast, activated microglia can also
exhibit decreased responsiveness to receptor stimulation. As
demonstrated recently, purinergic ligands evoked only attenu-
ated reactions in cells that were activated with bacterial lipopoly-
saccharide (LPS) (Mo¨ller et al., 2000b). LPS triggers activation of
macrophage-like cells and is used as a tool to mimic Gram-
negative infection (abd-el-Basset and Fedoroff, 1995; Ulevitch
and Tobias, 1995).
The intracellular calcium concentration ([Ca 2]i) influences
multiple cellular functions, including enzyme or release activi-
ties. Transient [Ca 2]i increases serve the intracellular signaling
of numerous plasma membrane receptors (Verkhratsky et al.,
1998). Also in microglia, several receptors are linked to the cal-
cium signaling machinery, e.g., those for “classical” neurotrans-
mitters as well as those for immune system mediators
(Kreutzberg, 1996; Nolte et al., 1996; Verkhratsky and Ketten-
mann, 1996; Mo¨ller et al., 1997; Boddeke et al., 1999; Hide et al.,
2000; Mo¨ller et al., 2000a,b). Calcium may serve as an integrator
of their cytosolic consequences to control microglial behavior
under resting and activated conditions.
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Amplitude and kinetics of a calcium signal are determined by
features of the ligand-receptor system and its cytosolic effector
cascade. This includes Ca 2 release from inositol-1,4,5-tri-
phopshate or ryanodine-sensitive intracellular Ca 2 stores, the
status of calcium release-activated calcium channels, and the ef-
ficacy of the calcium-buffering system (Verkhratsky et al., 1998).
However, the calcium signal might also be influenced by the
basal [Ca 2]i. Its level is maintained by the activity of calcium
pumps and the rate of constitutive Ca 2 influx. We demonstrate
that LPS activation of mouse microglia in vitro leads to elevated
basal [Ca 2]i along with attenuated Ca
2 signaling in response
to extracellular stimulation of selected purinoreceptors and com-
plement receptors. Furthermore, we present evidence that the
rise in [Ca 2]i is necessary to allow for characteristic features of
microglial activation, such as release of nitric oxide (NO) and
certain cytokines and chemokines. We hypothesize that an
activation-related lasting increase in the basal [Ca 2]i level crit-
ically determines receptor signaling efficacy and executive behav-
ior of macrophage-like cells.
Materials and Methods
Microglial cultures. Cells were prepared from newborn NMRI mice (Tier-
zucht Scho¨nwalde, Scho¨nwalde, Germany) and cultured in DMEM–10%
fetal calf serum as described previously (Prinz et al., 1999). Cells were
plated on glass coverslips (10 5 cells/cm 2, imaging and staining experi-
ments) or in Petri dishes (2  10 6 cells, biochemical analyses). Ninety-
eight percent of the cells were microglia, as revealed by staining (Prinz et
al., 1999). Cells were activated with LPS (100 ng/ml, Escherichia coli
K-235, 24 hr; Sigma, Deisenhofen, Germany). Incubations with BAPTA
AM (10 –50 M) (Sigma) and ionomycin (1–1000 nM) (Sigma) were
performed for the same time period.
Calcium measurements. Experiments were performed in HEPES buffer
(in mM: 150 NaCl, 5.4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES/NaOH, and 10
glucose, pH 7.35) at room temperature. [Ca 2]i was monitored using the
calcium-sensitive fluorescent indicator fura-2 AM. Cells were loaded
with fura-2 AM (5 M; stock solution in DMSO; Molecular Probes, Eu-
gene, OR) by incubation in bathing solution (30 min). For fura-2 exci-
tation, cells were illuminated with two alternating wavelengths, 340 5
and 380 5 nm. Excitation was performed by using a monochromator
(Polychrome IV; T.I.L.L. Photonics, Martinsried, Germany). The emit-
ted light was collected at 530  10 nm by the long-term exposure CCD
camera QuantiCam Long Exposure VGA-b/w (Phase, Luebeck, Ger-
many) coupled to a Zeiss (Oberkochen, Germany) Axioskop equipped
with a 20water immersion Zeiss objective (numerical aperture of 0.5).
The monochromator and CCD camera were controlled by Axon Imaging
Workbench 2.2 software (Axon Instruments, Union City, CA), being also
used for image processing. Data analysis was performed using standard
personal computer software. The [Ca 2]i was calculated from the ratio
(R) of fluorescence recorded at 340 and 380 nm excitation wavelengths.
Calibrations (conversion of R 340/380 values into molar calcium concen-
trations) were performed as described previously (Grynkiewicz et al.,
1985).
Cells were superfused with HEPES buffer, and images were taken every
3 sec. Basal [Ca 2]i was determined from the initial 10 images of each cell
recording. For eliciting [Ca 2]i transients, the superfusion medium was
switched for 30 sec to a solution of UTP, recombinant human comple-
ment factor 5a (C5a), or ATP (as survival control after measurements)
(100 M, 2 nM, and 100 M in HEPES buffer, respectively; Sigma). A
[Ca 2]i signal was defined as an increase in R 340/380 with clear time
correlation to the agonist application. Amplitudes (R) were calculated
as difference between R 340/380 basal and peak values.
CD88 immunocytochemistry. Cells were fixed (4% paraformaldehyde
in PBS, 20 mM Na2HPO4/NaH2PO4, pH 7.4, and 140 mM NaCl, 15 min)
and incubated in block solution [PBS, 2% bovine serum albumin (BSA),
and 2% normal rabbit serum (NRS), 1 hr], with PBS rinses in between
(two times for 15 min each), incubated with goat anti-mouse CD88
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) [2 g/ml in PBS,
0.1% BSA, and 0.1% NRS (PBS-B), 1 hr], rinsed (PBS-B, three times for
15 min each), and incubated with rabbit anti-goat-IgG F(ab)2-Cy3 (1:
200 in PBS-B, 1 hr; Jackson ImmunoResearch, West Grove, PA), and
rinsed in PBS-B (three times for 15 min each) and PBS (15 min). Cover-
slips were mounted under moviol (Sigma).
CD88 immunodetection. Cells were surface labeled with EZ-Link
sulfo–N-hydroxysuccinimidyl– biotin (1 mg/ml of PBS for 30 min at
room temperature; Pierce, Rockford, IL). After rinses with PBS, cells
were lysed in extraction buffer [20 mM Tris/HCl, pH 7.3, 140 mM NaCl,
0.5% Triton X-100, 150 U of DNase I (Worthington, Lakewood, NJ), and
one tablet per 50 ml of Complete protease inhibitors (Boehringer Mann-
heim, Mannheim, Germany) for 30 min] (Hanisch et al., 2001). After
freezing–thawing, anti-CD88 antibody (6 g/ml) was added for 75 min,
followed by 10 l/ml protein A/G resin (ImmunoCatcher; CytoSignal,
Irvine, CA). The mixture was rocked for another 30 min and transferred
to spin filters in microcentrifuge tubes equilibrated with mild lysis solu-
tion (ImmunoCatcher). After rinses, tubes were centrifuged (16,000 g,
1 min), and the resin was rinsed again, followed by centrifugation and
incubation with SDS-PAGE sample buffer. After centrifugation, the fil-
trates were collected, and lysate aliquots (protein measured by Mi-
croBCA assay; Pierce) were separated on a 10% SDS-PAGE gel and trans-
ferred to polyvinylidene difluoride membrane (Pierce). Membranes were
blocked with BSA (5%, 20 mM Tris/HCl buffer, pH 7.3, containing 150
mM NaCl, and TBS). Biotinylated CD88 was visualized with ExtrAvidin
peroxidase (at 1:100,000, TBS, containing 0.05% Tween 20 for 90 min;
Sigma), followed by ECL (Super Signal Ultra; Pierce). Another sample set
underwent analysis for total CD88 protein. After blocking, membranes
were incubated with anti-CD88 antibody (1g/ml in TBS, 0.05% Tween
20, and 10 mg/ml BSA for 90 min), rinsed, incubated with rabbit anti-
goat IgG antibody peroxidase (1:50,000 in TBS, containing Tween 20 and
BSA for 60 min; Sigma), washed, and developed by ECL.
Nitric oxid release. NO production was studied in cultures (24-well
plates with 1  10 5 cells per well) with and without stimulation by LPS
(100 ng/ml), BAPTA (10 –50 M), BAPTA and LPS, and ionomycin (1–
1000 nM). NO was determined in the supernatants after 24 hr by the
Griess reaction as accumulated nitrite, a breakdown product of NO,
using sodium nitrite as a standard. Each supernatant (100l) was mixed
with 100 l of Griess reagent and incubated at room temperature for 10
min. Optical density was determined in a microplate reader (1420 Victor;
Wallac Oy, Turku, Finland) at 540 nm wavelength.
Cytokine and chemokine release. Microglial cytokine and chemokine
release was assayed in 96-well plates with 5 10 4 cells per well after 6 and
24 hr of incubation in the absence or presence of LPS (100 ng/ml),
BAPTA (50M), BAPTA and LPS, or ionomycin (1–1000 nM). Superna-
tant samples were analyzed for mouse tumor necrosis factor  (TNF),
interleukin-6 (IL-6), total interleukin-12 (IL-12) (collecting the IL-12
forms p70, p40, and p402), macrophage inflammatory protein-1 (MIP-
1), and KC [the mouse equivalent of growth-related oncogene
(GRO)] in sandwich ELISA based on mouse- and factor-specific anti-
body pairs (R & D Systems, Wiesbaden, Germany) following the proce-
dure of the manufacturer. The color reaction was analyzed in a micro-
plate reader (SLT, Spectra; LabInstruments Deutschland, Crailsheim,
Germany). Total protein was determined using the MicroBCA protein
assay (Pierce).
Viability tests. Microglial metabolic activity was assayed in 96-well
plates with 5  10 4 cells per well using WST-1 reagent (4-[3-(4-
iodophenyl)-2-(4-nitrophenyl)-2 H-5-tetrazolio]-1,3-benzene disulfon-
ate) (Roche Diagnostics, Mannheim, Germany) according to the instruc-
tions of the manufacturer. The assay is based on the enzymatic cleavage of
WST tetrazolium salt to formazan by the succinate–tetrazolium reduc-
tase system of the respiratory chain of intact mitochondria. The color
reaction was measured in a microplate reader (1420 Victor; Wallac Oy) at
540 nm wavelength after 24 hr of incubation without and with LPS (100
ng/ml), BAPTA (50 M), BAPTA and LPS, and ionomycin (1–1000 nM).
In addition, cells were labeled by nuclear dyes to determine the
amount of surviving cells after an incubation. Staining with DAPI (4,6-
diamidino-2-phenylindoldihydro-chlorid) (Boehringer Mannheim)
showed the total amount of cells, whereas staining with ethidium bro-
mide (Molecular Probes) revealed the number of dead microglia. Cells
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were counted in four observation fields using a fluorescence microscope
(Zeiss Axioplan) with a 40magnification (numerical aperture of 0.75).
Statistical analysis. The effect of treatments between groups was tested
for statistical significance performing Mann–Whitney U test and  2 test
with SPSS software (SPSS, Chicago, IL). p  0.05 denoted statistical
significance.
Results
Activated microglial cells reveal attenuated calcium signaling
To study the impact of microglial activation on receptor-
mediated Ca 2 signaling, we compared untreated microglial cells
with those incubated with LPS (100 ng/ml for 24 hr). LPS is
commonly used as a model agent in studies on inducible micro-
glia–macrophage functions and bacterial CNS infections (Ha-
nisch, 2001). The LPS dose was chosen because it also relates to a
clinically relevant concentration range (Hanisch et al., 2001). For
eliciting transient increases in the [Ca 2]i, UTP and C5a were
applied. Both have functional receptors on microglia, which are
linked to calcium signaling, namely metabotropic purinergic re-
ceptors and CD88, respectively. In addition, initial experiments
also used ATP as another and previously studied purinoreceptor
ligand.
Addition of UTP (100M) or C5a (2 nM) for 30 sec to the bath
solution induced reproducible transient increases in the fura-2-
based calcium signal. An example of a trace (R 340/380) as re-
corded from an individual microglial cell under control condi-
tions is given in Figure 1A. The signal intensity and the shape of
the respective [Ca 2]i transients compared with previous reports
(Mo¨ller et al., 2000b). However, LPS-activated microglia gener-
ated much smaller [Ca 2]i signals for both of the ligands (Figs.
1B, 2A).
Averaging the recorded R 340/380 traces for a large number of
control (n 799 from nine independent experiments) (Fig. 1C)
and LPS-activated (n 754 from 10 experiments) cells (Fig. 1D)
revealed a significant suppression of the receptor-evoked calcium
signals, as illustrated for the response to UTP (for statistics, see
Table 1). For direct comparison, an overlay of the two graphs is
illustrated in Figure 1E. Figure 1, G and H, is amplitude histo-
grams of the Ca 2 responses of untreated and LPS-activated cells.
For each cell, the signal amplitude was calculated as the difference
between the basal R 340/380 signal (average of the first 10 re-
corded image frames) and the respective peak level of the UTP-
induced transient. According to their size, the amplitudes were
then classified into ranges. As reflected by the shift of the ampli-
tude distribution, activated microglia exhibited smaller UTP-
evoked increases in the [Ca 2]i (Table 1).
Microglial activation is accompanied by an increased resting
[Ca 2]i
Interestingly, a comparison of the [Ca 2]i traces in Figure 1E
revealed a marked increase in the basal level for the activated cells.
Figure 1F shows the values of basal [Ca 2]i in untreated and
LPS-activated cells as averaged from the first 10 image frames of
these traces (Table 1). Apparently, the reduction in receptor sig-
naling efficacy was paired with a general elevation in the basal
[Ca 2]i. The smaller response amplitudes superimposed on the
increased resting level in LPS-treated cells were, however, not
attributable to technical limitations in recording higher R 340/
380 values. The cells did not reach a ceiling level of fluorescence,
because amplitudes with higher maximal ratios were recorded in
control cells.
Surface expression of C5a receptors is not affected during
microglial activation
Attenuated signal intensity could be attributable to a downregu-
lation of the respective receptor. We thus determined whether
receptor expression was altered during LPS treatment. We fo-
cused on the receptor for C5a because it consists of a single pro-
tein, CD88, allowing for a convenient expression analysis. In con-
trast, UTP binds to a heterogeneous population of metabotropic
Figure 1. Rise in basal [Ca 2]i and attenuation of receptor-evoked Ca
2 signaling during
microglial activation. Microglial calcium signaling in response to UTP and C5a application was
compared between LPS-activated (100 ng/ml, 24 hr) and untreated cells (CTL). Using fura-2-
based imaging, [Ca 2]i was measured as the ratio of fluorescence at 340 and 380 nm (R
340/380). For eliciting calcium transients, UTP (100M), C5a (2 nM), and ATP (100M) were
added to the bath solution for 30 sec (bars, position indicating application, i.e., switch to the
corresponding bath solution). A, B, Representative [Ca 2]i traces of a control and a LPS-
stimulated cell. C, D, Average [Ca 2]i traces in control and LPS-stimulated cells as summarized
from 9 and 10 independent experiments with a total of n799 and n754, respectively. Data
are given as meanSEM. E, Overlay of the traces in C and D revealing the reduction in the signal
amplitude and the concomitant increase in basal [Ca 2]i during LPS activation. F, Comparison
of the average basal [Ca 2]i in control and LPS-treated microglia as calculated from the first 10
image frames of the cells in E. Data are mean SEM. G, H, Histograms of UTP-evoked [Ca 2]i
signal amplitudes in the control and LPS-stimulated cells (as for C and D). Amplitudes were
calculated as the difference between basal (average of the first 10 recorded image frames) and
peak R 340/380 values of each individual cell (R). Values ofR were classified into 10 ranges
(0R 0.05, 0.05R 0.10, etc.). The histogram for the LPS-activated cells clearly
shows a shift to smaller values.
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purinoreceptors (Ralevic and Burnstock, 1998). Immunocyto-
chemical staining for CD88 revealed a punctuated distribution
on microglia (Fig. 2B). Combination of biotin labeling of cell
surface molecules with subsequent anti-CD88 immunoprecipi-
tation revealed that neither the total nor the membrane-inserted
amounts of CD88 were affected by the LPS treatment (Fig. 2C).
LPS-induced changes in calcium signaling and basal [Ca 2]i
can be reversed by treatment with BAPTA
To test for a correlation between the elevated basal [Ca 2]i and
the impaired calcium signaling, we treated control and LPS-
activated cells with the intracellular calcium chelator BAPTA. We
used 50 M, a concentration efficient to affect LPS-induced re-
lease activity (shown below). Averaging the recorded R 340/380
traces of cells loaded with BAPTA only (n  705 from eight
independent experiments) (Fig. 3A) revealed no significant dif-
ference from untreated controls (Fig. 1C). The UTP response
amplitude as an indicator of the signaling capacity was not altered
(Fig. 3E, Table 1). This could be confirmed by also comparing the
amplitude histograms of UTP responses in the presence and ab-
sence of BAPTA (compare with Fig. 3G). Thus, BAPTA did not
impair calcium signaling.
In contrast, the averaged trace of cells treated with LPS in the
presence of BAPTA (n 591, 10 experiments) (Fig. 3B) showed
a marked difference compared with cells exposed to LPS alone
(Fig. 3C, Table 1). Cells treated with LPS in the presence of
BAPTA did not show the otherwise LPS-inducible rise in basal
[Ca 2]i (Fig. 3D). The basal [Ca
2]i equaled control conditions.
Moreover, the LPS-induced shift toward smaller amplitudes (Fig.
3H) was much less prominent in the presence of BAPTA (Fig.
3F), indicating partially restored signaling ability. These results
suggest that moderate chelation of intracellular calcium could,
indeed, revert the activation-induced decrease in signaling
efficacy.
Treatment with ionomycin can mimic the LPS-induced
changes in calcium signaling and basal [Ca 2]i
To test our hypothesis that the attenuated signaling ability in
activated microglia was attributable to the concomitant rise in
basal [Ca 2]i, we induced an elevation of the basal [Ca
2]i by
applying the calcium ionophor ionomycin. We postulated that
an ionomycin-mediated influx of calcium into the cytosol should
then hamper the signaling capacity. UTP stimulation of
ionomycin-treated cells should yield signaling amplitudes com-
parable with those of LPS-treated cells. Indeed, ionomycin load-
ing did not only cause the expected increase in basal [Ca 2]i (Fig.




p value Ratingc p value Ratingc
CTL–LPS 0.001 *** 0.000 ***
CTL–BAPTA 0.423 NS 0.159 NS
CTL–BAPTA LPS 0.400 NS 0.000 ***
CTL–ionomycin 0.018 * 0.000 ***
LPS–BAPTA 0.009 ** 0.000 ***
LPS–BAPTA LPS 0.002 ** 0.000 ***
LPS–ionomycin 0.313 NS 0.000 ***
BAPTA–BAPTA LPS 0.965 NS 0.000 ***
BAPTA–ionomycin 0.043 * 0.000 ***
BAPTA LPS–ionomycin 0.016 * 0.000 ***
aMann-Whitney U test.
b2 test.
cLevel of significance, from NS (not significant) to *** (highly significant).
Figure 2. Complement C5a-induced calcium signaling and expression of C5a receptors
(CD88) in microglia. A, To evoke [Ca 2]i transients, cells were stimulated with C5a by bath
application (2 nM, 30 sec; see bars). Calcium concentrations (nanomolar) were calculated from
fura-2-based fluorescence signals using calibration curves. The two traces illustrate represen-
tative recordings from individual microglial cells, as sampled from control cultures (CTL) and
cultures after a treatment with LPS (100 ng/ml, 24 hr). LPS-activated cells revealed a marked
suppression of the signal amplitude along with an increased basal [Ca 2]i (191 nM, n 25 vs
68 nM for the control, n 28). B, The micrographs illustrate an anti-CD88 immunofluorescence
staining of the C5a receptor in normal (untreated) microglial cells, revealing constitutive ex-
pression. Control staining (blank) omitting the primary antibody resulted in diffuse background
fluorescence only. C, Blot images show the results of CD88 immunoprecipitations from micro-
glial cultures. Immunoblotting revealed a single protein band in lysates of untreated microglia
(left), the apparent molecular weight being slightly smaller than expected. Note that the heavy
and light chains of the precipitating anti-CD88 IgG were also visualized by the staining protocol
using the same antibody for capturing and detection. To label membrane-associated CD88 in
microglia of LPS-treated (100 ng/ml, 24 hr) and control cultures, cell surface proteins were
biotinylated using a cell-impermeable N-hydroxysuccinimidyl derivative of biotin. Total CD88
protein was immunoprecipitated from the cellular lysates and immunodetected by anti-CD88
antibody. The biotinylated fraction of CD88 was separately stained using a streptavidin conju-
gate. The comparison of material obtained from untreated and LPS-treated cells suggested that
neither the total CD88 nor the biotin-labeled fraction changed during microglial activation.
Blots represent one of four experiments.
Hoffman et al. • Intracellular Calcium and Microglial Activation J. Neurosci., June 1, 2003 • 23(11):4410 – 4419 • 4413
4C, Table 1), as similarly seen with LPS treatment. Moreover, the
averaged trace of the UTP-evoked [Ca 2]i signal (n  515, six
experiments) (Fig. 4A) demonstrated a clear reduction of the
response peak when compared with untreated controls (Fig. 4B,
Table 1). Finally, histograms revealed a similar shift toward
smaller signaling amplitudes, as it was observed with LPS-
activated cells (Fig. 4D). Together, these results confirmed our
assumption that elevated basal [Ca 2]i as associating with micro-
glial activation may lead to attenuated receptor-evoked calcium
signaling.
LPS-induced NO and cytokine– chemokine release activities
are reduced in the presence of BAPTA
Chronic elevation of the basal [Ca 2]i after LPS activation could
be a central event in the microglial activation process. Therefore,
we tested whether microglial release activities in response to LPS
challenge were influenced by the basal [Ca 2]i level. We pre-
vented the LPS-inducible elevation of basal [Ca 2]i by BAPTA
administration and determined the outcomes for the production
of NO, as well as the release of certain cytokines and chemokines,
i.e., characteristic executive features of activated microglia.
Stimulation with LPS led to the expected strong increase in
NO production compared with untreated controls (Fig. 5A).
BAPTA treatment by itself did not have any effect. However, in
the presence of BAPTA, the LPS-induced NO production was
significantly reduced in a concentration-dependent manner as of
10M (Fig. 5A). Indeed, the release under 50M BAPTA declined
to control levels (Table 2).
Similarly, BAPTA affected the release of certain cytokines and
chemokines (Fig. 5B). LPS caused the extracellular accumulation
of the cytokines TNF, IL-6, and IL-12, as well as of the chemo-
kines KC (the rodent equivalent of GRO) and MIP-1. Super-
natants of untreated cultures were virtually devoid of any of these
cytokines and chemokines. In the presence of BAPTA, the release
of some factors was strongly suppressed, whereas that of others
was only slightly attenuated. IL-12 appeared to be most and
MIP-1 least affected by the BAPTA-mediated prevention of
LPS-induced [Ca 2]i elevation. The individual release reduction
was similar at the two time points studied during an ongoing
LPS–BAPTA treatment, i.e., 6 hr and 24 hr.
To exclude toxic BAPTA effects, metabolic activity was mon-
itored using the WST-based viability assay (Fig. 5C). BAPTA,
Figure 3. Influence of intracellular Ca 2 chelation on basal [Ca 2]i and UTP-evoked Ca
2
signals. Microglial cultures were incubated with BAPTA AM (50 M, 24 hr) in the absence or
presence of LPS (100 ng/ml), and [Ca 2]i was measured as R 340/380 (Fig. 1). Calcium tran-
sients were elicited by stimulation with UTP (100M, 30 sec). A, B, Average [Ca 2]i traces in
BAPTA-treated and BAPTA plus LPS-treated cells were calculated from 8 and 10 independent
experiments with a total of n705 and n591, respectively. Data are given as mean SEM.
C, Overlay of the traces obtained from LPS treatment only (Fig. 1 D) and from the combined
treatment with BAPTA plus LPS ( B) showing a prevention of the activation-mediated rise in
basal [Ca 2]i along with a partially restored [Ca
2]i transient. D, Comparison of the average
basal [Ca 2]i in control (CTL) and LPS-treated microglia as obtained with or without BAPTA
presence. Values were calculated as described in Figure 1. E, F, Histograms of UTP-evoked
[Ca 2]i signal amplitudes (R) in the cells under BAPTA (as in A) and cells with combined
BAPTA–LPS treatment (as in B). Amplitudes were calculated and classified as outlined in Figure
1. For a direct comparison, the situations in control and LPS-stimulated cells are shown again (G,
H ). The histograms reveal that BAPTA presence during the LPS challenge of microglia partially
prevented the activation-associated shift to smallerR values.
Figure 4. Influence of an ionophore-induced elevation of the basal [Ca 2]i on UTP-evoked
Ca 2 signals. Microglial cultures were incubated with ionomycin (1M, 24 hr), and [Ca 2]i
was measured as R 340/380. Calcium transients were elicited by stimulation with UTP (100M,
30 sec). A, Average [Ca 2]i trace in ionomycin-treated cells calculated from six independent
experiments with a total of n 515. Data are given as mean SEM. B, Overlay of the average
traces of ionomycin-treated and control (CTL) microglia (Fig. 1C) showing an elevated [Ca 2]i
together with a reduced amplitude of the receptor-evoked [Ca 2]i transient. C, Quantification
of the basal [Ca 2]i of ionomycin-treated microglia compared with the LPS and control groups
(Fig. 1 F). D, Histogram of UTP-evoked [Ca 2]i signal amplitudes (R) in cells after ionomycin
treatment (as in A). Amplitudes were calculated and classified as described in Figure 1. The
histogram indicates a shift of theR to smaller values as similarly obtained from LPS-activated
cells (Fig. 1 H).
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even at the highest concentration used for the calcium imaging
(50 M), did not show any change in the mitochondrial WST
cleavage activity (Fig. 5C). Similarly, life– death staining of
BAPTA AM-exposed microglia did not reveal impaired survival
(Fig. 5D). In addition, examination of the microglial gross mor-
phology did not indicate any BAPTA-induced alteration when
compared with the corresponding control situations (Fig. 6).
Thus, the observed decrease in release activities was unlikely to be
related to a reduced amount or vitality of cells.
These results indicate that a rise in basal [Ca 2]i during mi-
croglial activation is necessary for effective induction of NO, as
well as cytokines and chemokines. Nevertheless, it is not a man-
datory prerequisite for these features per se, because certain cy-
tokines and chemokines were less affected by BAPTA than others.
In addition, the fact that both soluble mediator “systems,” i.e.,
NO (as a diffusible gas) and cytokines– chemokines (as poly-
petides–proteins), were sensitive to BAPTA further points to
some implication of [Ca 2]i in the proximal steps of the induc-
tion cascades rather than an interference with later steps of release
performance.
Treatment with ionomycin cannot induce microglial release
The ionomycin-induced rise in basal [Ca 2]i had caused an LPS-
like effect on the UTP signaling, i.e., it attenuated Ca 2 responses
(Fig. 4). Assuming that an elevation of the basal [Ca 2]i is a
crucial step toward microglial release activities, we also tested
whether ionomycin treatment was sufficient to induce NO and
cytokine– chemokine production. However, none of the tested
concentrations was able to induce any release (Fig. 7A,B). This
failure was not attributable to toxic effects, because mitochon-
drial WST cleavage remained unchanged (Fig. 7C). In addition,
the survival rates of microglia in culture were found to be unaf-
fected (Fig. 7D). Finally, microscopic inspection of the cells did
not reveal signs of damage, although the morphology resembled
the appearance of LPS-challenged microglia (Fig. 6). The results
thus render unlikely that a lifting of the basal [Ca 2]i alone
could cause the production of NO or the initiation of cytokine–
chemokine induction pathways.
Discussion
Microglial activation is associated with an increase in the
resting [Ca 2]i
We found that exposure of microglia to LPS caused a significant
increase in the resting [Ca 2]i. Chronic elevations in the basal
[Ca 2]i level of up to 1 d have not yet been reported for microglia
but have been described for other CNS cell types. In cortical
neurons, amyloid  treatment leads to increased [Ca 2]i and
thereby to enhanced excitotoxicity (Mattson et al., 1992). Astro-
cytes from trisomy 16 mice, a model of human trisomy 21 (Down
syndrome), show abnormal calcium homeostasis with drastically
increased [Ca 2]i at rest (Bambrick et al., 1997). A finding similar
to our observation was reported for rat mesenteric arteries. Basal
[Ca 2]i was higher in vessels from LPS-treated animals com-
pared with controls (Martinez et al., 1996). In contrast, treatment
Figure 5. Effect of intracellular Ca 2 chelation on the basal and LPS-induced release of NO
and cytokines– chemokines, as well as on cell viability. Microglial cultures were treated with
varying concentrations of BAPTA AM in the absence or presence of LPS (100 ng/ml, 24 hr). A, NO
release measured as nitrite accumulation in the culture supernatant was determined and ex-
pressed as percentage of the amount obtained from LPS treatment only. BAPTA reduced the
LPS-induced NO production. Data are the mean SEM from at least three independent exper-
iments performed in triplicate. B, Cytokine and chemokine release in LPS-activated microglial
cultures in the presence of BAPTA (50M). Release values were determined as of 6 and 24 hr
and expressed as percentage of the respective value obtained from LPS treatment only. BAPTA
presence had a rather variable influence on individual factors, showing moderate to marked
reduction. Data are the mean SEM from three experiments (n 36 per group). C, Effect of
BAPTA (50M, 24 hr) on the cleavage of WST-1 by mitochondrial enzymes in control (CTL) and
LPS-treated microglia. Data are the mean SEM from six experiments (n 69 per group). D,
Effect of BAPTA (50M, 24 hr) on the survival of control and LPS-treated microglia as deter-
mined by a life– death staining assay. Data are the mean SEM from three experiments run in
duplicate. No BAPTA-related difference was detected by either of the vitality assays.





CTL–LPS BAPTA (10M) 0.016 *
CTL–LPS BAPTA (20M) 0.036 *
CTL–LPS BAPTA (50M) 0.095 NS
LPS–LPS BAPTA (10M) 0.016 *
LPS–LPS BAPTA (20M) 0.036 *
LPS–LPS BAPTA (50M) 0.008 **
aMann–Whitney U test.
bLevel of significance, from NS (not significant) to *** (highly significant).
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of the macrophage-like cell line P338D.1 with LPS for 8 hr rather
led to a reduction in the resting [Ca 2]i, whereas shorter activa-
tion periods had no consequence (Lowry et al., 1999). Moreover,
LPS treatment of osteoblasts did not alter basal [Ca2]i (Tam et al.,
1998). Apparently, the consequences of LPS signaling for the intra-
cellular calcium are not uniform and may depend on the cell type.
Little is known as to the mechanism linking proximal receptor
events of the LPS signaling to the regulation of calcium ho-
Figure 6. Morphology of microglial cells under LPS, BAPTA, and ionomycin treatment. Mi-
croglial cultures were treated for 24 hr with LPS (100 ng/ml), BAPTA AM (50M), a combination
of BAPTA and LPS, or ionomycin (1 M). Untreated cultures served as control (CTL). Images
demonstrate the appearance of cells in phase-contrast microscopy. During LPS treatment, cells
revealed the characteristic gross morphology known for activated cells in vitro, including shape
changes, granulation, and membrane ruffling.
Figure 7. Effect of an ionophore-induced elevation of the basal [Ca 2]i on the basal and
LPS-induced release of NO and cytokines– chemokines, as well as on cell viability. Microglial
cultures were treated with varying concentrations of ionomycin or with LPS (100 ng/ml, 24 hr).
Release of NO ( A) and cytokines– chemokines ( B) was determined as described in Figure 5.
Ionomycin did not induce any of the factors at any concentration (data for cytokines– chemo-
kines are shown here only for ionomycin at 1M). Data are the mean SEM from four ( A) and
three ( B) experiments, with an average of n 12 and n 36 per group, respectively. Iono-
mycin also had no influence on the vitality of microglial cultures as determined by WST-1
cleavage ( C) and life– death staining (D; data shown for 1M of the ionophore). Data are the
mean SEM from three experiments, each with an average of n 36 ( C) and n 6 ( D) per
group. CTL, Control.
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meostasis. Conceivably, an elevated basal [Ca 2]i could result
from enhanced constitutive Ca 2 influx, from a reduced activity
of Ca 2 extrusion pumps, or from a reduction in Ca 2 buffer
activity. Indeed, a chronically increased Ca 2 influx can be trig-
gered in microglia during massive depletion of cytoplasmic stores
(Toescu et al., 1998). LPS in conjunction with LPS binding pro-
tein binds to the CD14 –Toll-like receptor complex to induce
cytosolic signaling and nuclear events (Schumann et al., 1990;
Ulevitch and Tobias, 1995; Kirschning et al., 1998; Guha and
Mackman, 2001). Several kinases and phosphorylation cascades
have been shown to be recruited (Ulevitch and Tobias, 1995;
Guha and Mackman, 2001; Hanisch et al., 2001). However, there
is yet no evidence for direct LPS effects on Ca 2 pumps.
Activated microglial cells show an attenuated calcium signaling
Whereas LPS treatment resulted in an increased basal [Ca 2]i,
the activated cells showed a decreased responsiveness to external
stimulation with UTP. We described previously that microglial
activation resulted in a reduced diversity of purinoreceptor sig-
naling (Mo¨ller et al., 2000b). Now, we could correlate the lifting
in basal [Ca 2]i to a suppressed purinoreceptor signaling (Fig. 8).
Moreover, we also studied another microglial ligand-receptor
system, i.e., C5a signaling through its receptor CD88 (Gasque et
al., 1997; Mo¨ller et al., 1997; Nataf et al., 1999; Van Beek et al.,
2000). Similar to purinergic signaling, C5a responses revealed the
very same principle of regulation with elevated basal [Ca 2]i and
reduced amplitudes after treatment with LPS. In addition, CD88
as the sole receptor for C5a allowed for the convenient demon-
stration that the amount of membrane-expressed receptor pro-
tein was not altered by LPS treatment, suggesting that attenuated
C5a responsiveness was not attributable to a decrease in
receptors.
Adaptation of the calcium signaling behavior appears to be a
widespread phenomenon. LPS treatment of C6 glioma cells led to
an inhibition of serotonin- and thrombin-evoked signaling
(Tawara et al., 1998). In osteoblasts, LPS activation altered para-
thyroid hormone- and prostaglandin E2-induced Ca
2 influx
and affected Ca 2 release from stores, although these changes
were not accompanied by a concomitant alteration of the resting
calcium level (Kugaya et al., 1997; Tam et al., 1998).
Elevation of basal [Ca 2]i as a central regulatory event in
microglial activation
Could an elevation of the basal [Ca 2]i be causally linked to the
reduced ability of activated microglia to respond to an external
stimulus with a [Ca 2]i transient? We addressed this question in
two experimental approaches. First, chelation of the free cytosolic
calcium in LPS-activated microglia by intracellular presence of
BAPTA did not only bring the [Ca 2]i back to control level but
also restored much of the purinoreceptor signaling capacity. Sec-
ond, the opposite setting, namely an ionophore-imposed rise in
[Ca 2]i in naive cultures (no LPS treatment), impaired the ability
for receptor-evoked calcium signaling, much in the same way as
seen under LPS. In our model, calcium thus serves a “gating”
function in the conversion of extracellular stimulations to cyto-
solic consequences, low basal [Ca 2]i being permissive and in-
creased levels elevating the threshold for a response to build up.
This link between calcium homeostasis and calcium signaling
as seen in brain macrophages may even stand for a more general
principle. Indeed, such an apparent coincidence was also de-
scribed in B and T lymphocytes. Elevated basal [Ca 2]i as seen in
chronically activated B cells correlated with a reduced respon-
siveness to B cell receptor stimulation (Healy et al., 1997). It was
further suggested that the amplitude and duration of [Ca 2]i
changes determine the differential recruitment of downstream
signaling elements in these cells (Dolmetsch et al., 1997). Simi-
larly, elevated basal [Ca 2]i was reported in B cells of Ig-
transgenic mice along with refractory B cell receptor-mediated
calcium mobilization and protein kinase activity (Benschopp et
al., 2001). A causal relationship between elevated cytosolic free
calcium and a suppressed calcium-mediated signal transduction
Figure 8. Schematic summary of the experimentally induced adaptations of microglia. Un-
stimulated microglial cells (shown on the left) in vitro typically appearing with a short-
processed, nonbranched or rod-shaped morphology responded to UTP and C5a receptor stim-
ulation with the generation of a [Ca 2]i transient but did not show signs of release activity,
similar to the “resting” ramified microglia of the normal brain tissue. A challenge of these cells
under pathological conditions, as mimicked here by a treatment with bacterial LPS, led to a
complex morphological and functional transformation known as microglial activation. In the
present study, LPS-activated cells were characterized by an elevated basal [Ca 2]i level along
with a suppressed ability to generate receptor-triggered [Ca 2]i signals. Strong release of NO
as well as cytokines and chemokines was measured. LPS treatment in the presence of BAPTA
nearly restored the receptor signaling efficacy, paralleled by an almost back-to-normal basal
[Ca 2]i and an attenuated release performance. On the other hand, direct enforcement of a rise
in basal [Ca 2]i by microglial incubation with ionomycin also suppressed the signal amplitudes
but failed to trigger an LPS-like release pattern. Together, these observations suggest that an
elevated basal [Ca 2]i participates in the functional adjustment of activated microglia, without
being the sole cytosolic control element for executive features, such as NO and cytokine– che-
mokine production.
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has also been published recently for Jurkat (T) cells (Boldizsar et
al., 2002).
Although the increase in basal [Ca 2]i obviously affected the
sensory limb of microglial functions as it relies on a receptor-
triggered calcium signal generation, we also obtained evidence
for outcomes on the executive properties of these cells.
Consequences of activation-associated changes in the
[Ca 2]i regulation
Calcium as a second-messenger system influences enzymes, ion
channels, and cytoskeletal elements. It also exerts a control on
gene transcription (Berridge, 2001). A significant portion of the
executive features of activated microglia, i.e., the production of
immunoregulatory and neuroregulatory cytokines and chemo-
kines, depends on the de novo synthesis of proteins. We provide
evidence for a differential regulation of cytokine– chemokine in-
duction by [Ca 2]i. Calcium buffering by BAPTA had an atten-
uating influence on five studied proteins, the outcome ranging
from strong to moderate suppression. Similarly, the production
of the diffusible mediator, NO was suppressed under BAPTA.
Still, this pattern of individual downregulation indicated that the
calcium chelation was not generally affecting the synthesis and
release machineries (Fig. 8).
On the contrary, calcium did not dictate cytokine– chemokine
induction by itself. Bypassing the LPS receptor system and just
lifting [Ca 2]i through an ionophore failed to trigger their re-
lease. For cytokines– chemokines, the signaling cascades from the
LPS receptor system to their induction thus likely require more
than a single route (Marriott et al., 1998; Hanisch et al., 2001).
Our data indicate that calcium is not the only control element for
the induction of cytokines– chemokines but rather assists in (or
facilitates) this process. Ionomycin also failed in driving NO pro-
duction. Apparently, the activities of NO-synthesizing enzymes
are under a similar type of complex control. Calcium is needed
for developing full activity but is unable to trigger any synthesis
on its own. This assumption is supported by the fact that the
“calcium-dependent” (calcium-inducible) version of NO syn-
thases is, indeed, absent in microglia (Agullo et al., 1995).
However, increased basal [Ca 2]i levels per se may not neces-
sarily translate into always the same sensory or functional adjust-
ments. In peritoneal macrophages, an experimental elevation of
the resting [Ca 2]i by ionophores did induce NO synthase and
thus mimicked LPS (Raddassi et al., 1994). On the contrary,
[Ca 2]i elevation in articular chondrocytes led to an almost op-
posite effect. Ionophores did not trigger NO release but even
inhibited an IL-1-induced NO production (Geng and Lotz,
1995).
Decreased ability to translate receptor stimulation into
[Ca 2]i transients could represent an intrinsic mechanism of ac-
tivated cells to shut off sensitivity toward external influences. It
could thereby indirectly attenuate additional executive reactions
to extracellular signals, as far as they are under the control of
[Ca 2]i. In addition, downregulation of stimulus-evoked
[Ca 2]i increases may serve some protective function because an
excessive [Ca 2]i elevation may result in detrimental conse-
quences for microglial cells and their primarily protective action.
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